MétaCan
Menu
Back to cohort
Record W2886172422 · doi:10.3389/fimmu.2018.01894

Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response

2018· article· en· W2886172422 on OpenAlexafffund
Dakota Rogers, Ava Vila-Leahey, Ana Clara Pessôa, Sharon A. Oldford, Paola A. Marignani, Jean S. Marshall

Bibliographic record

VenueFrontiers in Immunology · 2018
Typearticle
Languageen
FieldImmunology and Microbiology
TopicMast cells and histamine
Canadian institutionsDalhousie University
FundersCanadian Cancer Society Research Institute
KeywordsRanitidineAntibodyFlow cytometryMedicineHistamineCirculating tumor cellImmunologyMetastasisCancer researchCancerPharmacologyInternal medicine

Abstract

fetched live from OpenAlex

Background: The histamine receptor 2 antagonist ranitidine is a commonly used, non-prescription, medication. It limits the development, growth and metastasis of breast cancers in mouse models of disease. In the current study, we examined the role of B cells in this response, the impact of ranitidine on the development of anti-tumor antibodies and subpopulations of natural killer cells using murine breast cancer models. Methods: Peripheral blood granulocyte populations were assessed in both E0771-GFP and 4T1 orthotopic tumor bearing mice by evaluation of stained blood smears. Antibody responses were assessed both in terms of the levels of anti-GFP antibodies detected by ELISA and also by antibody binding to the surface of tumor cells evaluated by flow cytometry. B cell and NK cell populations were examined in the draining lymph nodes and spleens of tumor bearing animals, by flow cytometry with and without ranitidine treatment. Results: Oral ranitidine treatment was not associated with changes in peripheral blood granulocyte populations in tumor-bearing mice. However, ranitidine treatment was associated with the development of enhanced anti-tumor antibody responses. This was not limited to the tumor setting since ranitidine treated mice immunized with ovalbumin also demonstrated increased IgG antibody responses. Analysis of B cell populations indicated that while B1 cell populations remained unchanged there was a significant decrease in B2 cells in the tumor draining inguinal lymph nodes. Notably, ranitidine did not significantly inhibit primary tumor growth in B cell-deficient animals. Examination of NK cell populations revealed a significant decrease in the proportion of intermediately functionally mature NK cells populations (CD27+CD11b-in ranitidine-treated tumor bearing mice compared with untreated tumor bearing controls. Conclusions: These data demonstrate an important role for B cells in the enhanced anti-tumor immune response that occurs in response to ranitidine treatment. Our findings are consistent with a model whereby ranitidine reduces tumor associated immune suppression allowing for the development of more effective anti-tumor responses mediated by B cells which may include the participation of NK cells. These data underline the importance of considering widely used histamine receptor antagonists as modulators of anti-tumor immunity to breast cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.140
Threshold uncertainty score0.834

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.202
Teacher spread0.198 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueFrontiers in ImmunologySame topicMast cells and histamineFrench-language works237,207